Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2001
06/21/2001CA2394428A1 Method for detecting target nucleotide sequences
06/21/2001CA2394269A1 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements
06/21/2001CA2394167A1 Compositions and methods for inhibiting endothelial cell proliferation
06/21/2001CA2394160A1 Human oxidoreductase proteins
06/21/2001CA2394152A1 Method for obtaining human cdc25 phosphatases and method for identifying human cdc25 phosphatase modulators
06/21/2001CA2394126A1 Method and device for detecting and quantifying biomolecules
06/21/2001CA2393844A1 Methods and compositions for the manufacture of replication incompetent adenovirus
06/21/2001CA2393834A1 Wasp family protein fragments, and use therof
06/21/2001CA2393620A1 Method to evaluate the hiv drug sensitivity
06/21/2001CA2393292A1 Brain specific binding members
06/21/2001CA2392239A1 Use of fluorescence correlation spectroscopy to identify compounds that bind to target species under isothermal denaturing conditions
06/21/2001CA2390689A1 Human lyases and associated proteins
06/21/2001CA2390674A1 Antisense oligonucleotides for the inhibition of expression of type i procollagen
06/21/2001CA2390662A1 Bcl-g polypeptides, encoding nucleic acids and methods of use
06/21/2001CA2363100A1 Genetic variants of the human fsh receptor and the influence thereof on gametogenesis
06/20/2001EP1109021A1 Snail, new tumoral progression marker and target protein of new antitumoral compounds
06/20/2001EP1109019A1 Method to evaluate the sensitivity of HIV variants to drugs able to inhibit the HIV protease
06/20/2001EP1108791A1 Genetic variants of the human FSH receptor and the influence thereof on gametogenesis
06/20/2001EP1108790A2 Novel polynucleotides
06/20/2001EP1108789A2 Quantitation of hTERT mRNA Expression
06/20/2001EP1108788A1 Method for screening srebp pathway-specific inhibitors
06/20/2001EP1108787A2 Production of vaccines
06/20/2001EP1108784A1 Placental organic anion transporter and gene thereof
06/20/2001EP1108783A2 Oligonucleotide-mediated nucleic acid recombination
06/20/2001EP1108781A2 Method for making character strings, polynucleotides and polypeptides
06/20/2001EP1108472A2 Advanced thermal gradient DNA chip (ATGC), it's manufacture method and method for carrying out biochemical reactions
06/20/2001EP1108432A1 Method for identifying or isolating a molecule and molecules indentified thereby
06/20/2001EP1108213A1 Method of electrochemical analysis of an analyte
06/20/2001EP1108212A1 Methods and materials for diagnosing unstable angina
06/20/2001EP1108211A1 Method for testing the toxicity of chemical substances using gastropods
06/20/2001EP1108069A1 Method for assessing the relative purity of viral gene transfer vector stocks
06/20/2001EP1108068A1 T-type calcium channel
06/20/2001EP1108067A2 Toxicological response markers
06/20/2001EP1108066A2 Reaction chambers coated with defined concentrations of nucleic acids, method for the production and use thereof
06/20/2001EP1108065A1 A method for measuring a patient's ability to metabolise certain drugs
06/20/2001EP1108064A2 Oligo nucleotides, method and kit for detecting listeria monocytogenes by amplifying and/or hybridizing nucleic acids
06/20/2001EP1108063A1 Rapid amperometric verification of pcr amplification of dna
06/20/2001EP1108062A1 Use of pooled probes in genetic analysis
06/20/2001EP1108061A1 Method for amplifying all dna fragments in a sample
06/20/2001EP1108060A1 MOLECULAR DIFFERENCES BETWEEN SPECIES OF THE $i(M. TUBERCULOSIS) COMPLEX
06/20/2001EP1108059A2 Nucleic acids encoding human tbc-1 protein and polymorphic markers thereof
06/20/2001EP1108058A1 Evolution of whole cells and organisms by recursive sequence recombination
06/20/2001EP1108057A1 Method, equipment and reagent for cell separation
06/20/2001EP1108056A1 Method for testing anti-bacterial attachment compositions
06/20/2001EP1108055A1 Methods and systems for predicting protein function
06/20/2001EP1108054A1 Method for the production of sialylated oligosaccharides
06/20/2001EP1108046A1 Guanylate binding protein (gbp-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
06/20/2001EP1108044A2 A new method of identifying non-host plant disease resistance genes
06/20/2001EP1108037A1 Nucleic acid molecules which code for enzymes with fructosyltransferase activity and use thereof
06/20/2001EP1108033A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF
06/20/2001EP1108026A1 Nucleic acids encoding ataxin-2 binding proteins, products related thereto and methods of using same
06/20/2001EP1108025A2 Phelix: a testis-specific protein expressed in cancer
06/20/2001EP1108024A1 Lim domain protein homolog
06/20/2001EP1108023A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
06/20/2001EP1108022A1 Cell specific promoters of uncoupling protein 3
06/20/2001EP1108021A2 Human genes differentially expressed in colorectal cancer
06/20/2001EP1108020A1 Glycine transporter
06/20/2001EP1108019A2 Protein transport-associated molecules
06/20/2001EP1108016A2 Mapkap kinase 2-inhibitors and the use thereof in anti-inflammatory therapy
06/20/2001EP1108013A2 Genes associated with neurotransmitter processing
06/20/2001EP1108008A1 Novel ubiquitin ligases as therapeutic targets
06/20/2001EP1108006A1 Self-contained device integrating nucleic acid extraction, amplification and detection
06/20/2001EP1107987A2 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor
06/20/2001EP1107986A1 Protein domains in the hepatic glycogen-targeting subunit of protein phosphatase 1 and methods of making and using the same
06/20/2001EP1107977A1 Ratc
06/20/2001EP1107798A1 A novel method of diagnosing, monitoring, staging, imaging and treating colon cancer
06/20/2001EP1107797A2 Hypoxia regulated genes
06/20/2001EP1107789A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
06/20/2001EP1107788A1 Scrp-5: secreted cysteine rich protein-5
06/20/2001EP1107780A2 Selective treatment of endothelial somatostatin receptors
06/20/2001EP1107774A1 Ramp2a: receptor activity modifying protein-2a
06/20/2001EP0886778B1 Synthetic test soil
06/20/2001EP0842188A4 Mutant s182 genes
06/20/2001EP0662157B1 Compositions and methods for treatment of hepatitis c virus-associated diseases
06/20/2001CN2435400Y Micro-organism sensitive drug screening case
06/20/2001CN1299973A HCV-free-blood external preparing method
06/20/2001CN1299971A Turbidity measuring ultramicro-detecting technology and method using multifunctional biochemical enzyme labelling analyzer
06/20/2001CN1299969A Inorganic ion ultramicro-detecting technology and method using multifunctional biochemical enzyme labelling analyzer
06/20/2001CN1299878A Fast medicine sensitivity screening method for tubercle bacillus
06/20/2001CN1299877A Chip for the separation, analysis and treatment of bacteria and cells
06/20/2001CN1299876A Cell structure dectecting method
06/19/2001US6249341 Imaging and analyzing parameters of small moving objects such as cells
06/19/2001US6248934 Gene trap vectors
06/19/2001US6248873 Nucleotide sequences associated with cardiovascular disorders; for the detection of genetic adjustment in the genome
06/19/2001US6248872 Nucleotide sequences which code enzymatic protein; for use in detection and treatment of dirofilaria infection
06/19/2001US6248867 Polypeptide associated with proper eye function; for the diagnosis of vision defects
06/19/2001US6248712 Urokinase-type plasminogen activator receptor
06/19/2001US6248594 Kinesin-like motor protein
06/19/2001US6248589 Recombinant hepatitis C virus RNA replicase
06/19/2001US6248581 Mycobacteria functional screening and/or expression vectors
06/19/2001US6248578 Infectious clone for human parainfluenza virus type 3
06/19/2001US6248576 Histidinol dehydrogenase
06/19/2001US6248568 Hybridizing oligonucleotide primer to template nucleic acid and adding primer extension reagents including a nucleoside compound of defined structure; nucleotides for use as chain terminating substrates in fluorescence based sequencing
06/19/2001US6248557 RatC
06/19/2001US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells
06/19/2001US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors
06/19/2001US6248553 Detecting disease by digesting lysophosphatidic acid in body fluid sample with first enzyme, reacting produced substrate with second enzyme, measuring detectable product, then comparing to normal concentration; for gynecological cancer
06/19/2001US6248552 Adding reduced nicotinamide-adenine dinucleotide to sample of whole blood containing endogenous oxidoreductase, measuring amount oxidized, then correlating amount with energy capacity of cells in sample
06/19/2001US6248550 Assays for protein kinases using fluorescent protein substrates
06/19/2001US6248549 Methods of modulating muscle contraction